Santhera Acquires Juvantia and Secures All Rights to JP-1730/Fipamezole
17-Aug-2009 -
Santhera Pharmaceuticals announced that it exercised its option to acquire Oy Juvantia Pharma Ltd of Turku, Finland, the owner of JP-1730/fipamezole. Santhera will issue up to 105,973 previously reserved shares from its authorized capital to Juvantia investors subject to certain conditions. ...
dyskinesia
Finland
Parkinson's disease
+1